Cidara Therapeutics, Inc. - Common Stock (NQ:CDTX)

220.05 -0.05 (-0.02%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 16, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cidara Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 27, 2022

Via Benzinga

Cidara Pursues FDA Approval For Bloodstream Infections Candidate ↗

July 27, 2022

Cidara Therapeutics, Inc. (NASDAQ: CDTX) has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its lead asset Rrezafungin for the treatment of candidemia and...

Via Benzinga

With FDA Submission, Cidara Therapeutics Inks US Pact For Bloodstream Infection Candidate ↗

July 27, 2022

Via Benzinga

Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy ↗

July 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Recap: Cidara Therapeutics Q1 Earnings ↗

May 11, 2022

Cidara Therapeutics (NASDAQ:CDTX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 27, 2022

Via Benzinga

Cidara Therapeutics Submits NDA for Rezafungin and Announces License Agreement with Melinta Therapeutics for Commercialization of Rezafungin in the U.S.

July 27, 2022

From Cidara Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 25, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 19, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 11, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 09, 2022

Gainers Reshape Lifesciences (NASDAQ:RSLS) shares rose 9.4% to $0.81 during Thursday's after-market session. The market value of their outstanding shares is at $2.8 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 08, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 16, 2022

Via Benzinga

83 Biggest Movers From Yesterday ↗

June 09, 2022

Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly...

Via Benzinga

50 Stocks Moving In Wednesday's Mid-Day Session ↗

June 08, 2022

Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) shares gained 81% to $1.8503 after the company authorized a $3.5 million buyback.

Via Benzinga

Read Why HC Wainwright Lowered Price Target On This Small Biotech Stock ↗

May 12, 2022

U.S. marketing application filing for Cidara Therapeutics Inc's (NASDAQ: CDTX) rezafungin remains on track for mid-2022, setting up a potential early 2023 approval and launch.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 12, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

June 06, 2022

Monday's session saw 84 companies set new 52-week lows.

Via Benzinga

The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More ↗

April 24, 2022

Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering...

Via Benzinga

90 Biggest Movers From Yesterday ↗

May 13, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 12, 2022

Good morning! It's time for another dive into the market this morning with a look at the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 01, 2022

Gainers Yumanity Therapeutics (NASDAQ:YMTX) shares rose 13.3% to $1.7 during Friday's pre-market session. The market value of their outstanding shares is at $18.4...

Via Benzinga

Cidara Therapeutics's Return On Capital Employed Insights ↗

March 10, 2022

According to Benzinga Pro data, during Q4, Cidara Therapeutics (NASDAQ:CDTX) posted sales of $7.22 million. Earnings were up 7.08%, but Cidara Therapeutics still reported an...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 02, 2022

Gainers Eargo (NASDAQ:EAR) shares rose 10....

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 01, 2022

Gainers Avenue Therapeutics (NASDAQ:ATXI) shares rose 102.3% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $14.3...

Via Benzinga

FDA Clears Cidara Therapeutics' Phase 1 Trial For Immunotherapeutic Antiviral For Influenza ↗

February 14, 2022

The FDA has signed off Cidara Therapeutics Inc's (NASDAQ: CDTX) Investigational New Drug (IND) application for its lead flu drug-Fc conjugate (DFC), CD388 for...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 03, 2022

Gainers Cidara Therapeutics (NASDAQ:CDTX)...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 20, 2021

Gainers Intra-Cellular Therapies (NASDAQ:ITCI) stock rose 18.79% to $46.52 during Monday's pre-market session. The market value of their outstanding shares is at $3.7...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

January 07, 2022

Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap...

Via Benzinga

Cidara Therapeutics Stock Slides Despite Acing Rezafungin Trial In Fungal Infection ↗

December 14, 2021

Cidara Therapeutics Inc (NASDAQ: CDTX) and Mundipharma posted topline data from the ReSTORE Phase 3 trial of rezafungin for candidemia and invasive candidiasis...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.